KYLE GUTERBA: Open Payments
NPI 1093239717 · AUSTINTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,778 in 160 payments from 14 companies in 2025. Trend: 2023 $29,149 · 2024 $17,461 · 2025 $17,778
Honoraria: $11,863Food & beverage: $3,056Speaker / faculty: $1,500Travel & lodging: $1,250Education: $109
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 37 | $13,787 |
| ABBVIE INC. | 24 | $1,850 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $375 |
| Teva Pharmaceuticals USA, Inc. | 17 | $313 |
| Vanda Pharmaceuticals Inc. | 10 | $265 |
| E.R. Squibb & Sons, L.L.C. | 12 | $243 |
| Lundbeck LLC | 18 | $194 |
| Neurocrine BioSciences, Inc. | 6 | $181 |
| Alkermes, Inc. | 5 | $170 |
| Otsuka America Pharmaceutical, Inc. | 8 | $160 |
Products named: Auvelity, VRAYLAR, CAPLYTA, FANAPT, COBENFY, ABILIFY MAINTENA, AUSTEDO XR, INGREZZA.
Industry payments across OH — which companies pay providers there.
